Aparna Ramaseshan, MD
Urogynecology and Reconstructive Pelvic Surgery · Baltimore, MDNPI 1790121846
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,513 of the $3,041 with a category attached, or 82.6%. 24 manufacturers reported payments, led by Axonics, Inc. at 25.8% of the total. 2025 is the largest year on record at $1,259, more than ten times the $68 reported in 2020.
Across 92 payments — averaging $33.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$785
- AbbVie$423
- Sumitomo Pharma America, Inc.$400
- Boston Scientific$352
- Caldera Medical, Inc$246
- Endo USA, Inc.$157
- plus $677 from 18 others
What the payments were for
- Speaking & faculty fees$1124%
- Travel & lodging$41614%
- Food & beverage$2,51383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 20 | $785 |
| AbbVie(2 entities) | 13 | $423 |
| Sumitomo Pharma America, Inc. | 14 | $400 |
| Boston Scientific | 9 | $352 |
| Caldera Medical, Inc | 1 | $246 |
| Endo USA, Inc. | 7 | $157 |
| Bayer | 3 | $81 |
| Tolmar, Inc. | 3 | $73 |
| Merck | 3 | $66 |
| Pfizer | 2 | $49 |
| Applied Medical Resources Corporation | 1 | $49 |
| Antares Pharma, Inc. | 2 | $48 |
| Johnson & Johnson | 2 | $43 |
| Teleflex LLC | 1 | $37 |
| Caris MPI, Inc. | 1 | $33 |
| Medtronic | 2 | $33 |
| BD | 1 | $28 |
| Blue Earth Diagnostics | 1 | $25 |
| Ambu Inc. | 1 | $23 |
| Urogen Pharma, Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Coloplast | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Valencia Technologies Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 68 | $4,446 |
| Methenamine Hippurate | 15 | $556 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $143 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Baltimore
- Robert GutmanBaltimore$28K
- Joan BlomquistBaltimore$4K
- Neha GaddamBaltimore$2K
- Tola FashokunBaltimore$1K
- Victoria HandaBaltimore$140
- Mava Robinson-WaltonSilver Spring$257K
- Daniel GruberBethesda$91K
- Anita Pillai AllenSilver Spring$38K
- Aisha TaylorHanover$29K
- Yong ZhengBowie$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.